114
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Is the double gene dose of DQ2.5 or DQ2.5/DQ2.2 an involved factor in the clinical features of celiac disease?

, &
Pages 960-964 | Received 24 May 2019, Accepted 16 Jul 2019, Published online: 30 Jul 2019

References

  • Ploski R, Ek J, Thorsby E, et al. On the HLA-DQ (alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens. 1993;41:173–177.
  • Margaritte-Jeannin P, Babron MC, Bourgey M, et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens. 2004;63:562–567.
  • Pietzak MM, Schofield TC, McGinniss MJ, et al. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol. 2009;7:966–971.
  • Vader W, Stepniak D, Kooy Y, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA. 2003;100:12390–12395.
  • Zubillaga P, Vidales MC, Zubillaga I, et al. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J Pediatr Gastroenterol Nutr. 2002;34:548–554.
  • Karinen H, Kärkkäinen P, Pihlajamäki J, et al. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol. 2006;41:191–199.
  • Jores RD, Frau F, Cucca F, et al. HLA-DQB1*0201 homozygosis predisposes to sever intestinal damage in celiac disease. Scand J Gastroenterol. 2007;42:48–53.
  • Nenna R, Mora B, Megiorni F, et al. HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease. J Pediatr Gastroenterol Nutr. 2008;47:288–292.
  • Bajor J, Szakács Z, Juhász M, et al. HLA-DQ2 homozygosis increases tTGA levels at diagnosis but does not influence the clinical phenotype of coeliac disease: a multicentre study. Int J Immunogenet. 2019;46:74–81.
  • Murray JA, Moore SB, Van Dyke CT, et al. HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol. 2007;5:1406–1412.
  • Vermeulen BA, Hogen Esch CE, Yuksel Z, et al. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol. 2009;44:40–45.
  • Cabrera CM, Méndez-López IM, Caballero A. Risk variation in celiac disease in a population from Southern Spain: evaluating the influence of the DQB1*02:02 allele frequency. Scand J Gastroenterol. 2018;53:266–272.
  • Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.
  • Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.
  • Bajor J, Szakács Z, Farkas N, et al. Classical celiac disease is more frequent with a double dose of HLA-DQB1*02: a systematic review with meta-analysis. PLoS One. 2019;14:e0212329.
  • Congia M, Cucca F, Frau F, et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol. 1994;40:138–142.
  • Gudjónsdóttir AH, Nilsson S, Naluai AT, et al. Association between genotypes and phenotypes in coeliac disease. J Pediatr Gastroenterol Nutr. 2009;49:165–169.
  • Cakir M, Baran M, Uçar F, et al. Accuracy of HLA-DQ genotyping in combination with IgA anti-tissue transglutaminase serology and a “scoring system” for the diagnosis of celiac disease in Turkish children. Turk J Pediatr. 2014;56:347–353.
  • Cabrera CM, Urra JM, Alfaya T, et al. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy. Mol Immunol. 2014;62:178–785.
  • Cooper BT, Holmes GK, Cooke WT. Coeliac disease and immunological disorders. Br Med J. 1978;1:537–539.
  • Williams AJ. Coeliac disease and allergic manifestations. Lancet. 1987;1:808.
  • Kero J, Gissler M, Hemminki E, et al. Could Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol. 2001;108:781–783.
  • Ludvigsson JF, Hemminki K, Wahlström J, et al. Celiac disease confers a 1.6-fold increased risk of asthma: a nationwide population-based cohort study. J Allergy Clin Immunol. 2011;127:1071–1073.
  • Kärhus LL, Skaaby T, Madsen AL, et al. The association of celiac disease and allergic disease in a general adult population. United European Gastroentrol J. 2019;7:78–89.
  • Ciacci C, Cavallaro R, Iovino P, et al. Allergy prevalence in adult celiac disease. J Allergy Clin Immunol. 2004;113:1199–1203.
  • Greco L, De Seta L, D'Adamo G, et al. Atopy and coeliac disease: bias or true relation? Acta Paediatr Scand. 1990;79:670–674.
  • Koning F. Pathophysiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59:S1–S4.
  • Tjon JM, van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics 2010;62:641–651.
  • Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42:295–302.
  • Wijmenga C, Gutierrez-Achury J. Celiac disease genetics: past, present, and future challenges. J Pediatr Gastroenterol Nutr. 2014;59:S4–S7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.